CNY-20305-46210 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-04-11
Dose 1 — Pfizer-BioNTech
2022-05-13
Dose 2 — Pfizer-BioNTech
2022-06-21
Registered in v-safe
2022-06-21
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-06-25
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-08-14
Survey response — 3 months, dose 2, dependent
MedDRA: Fatigue, Pyrexia, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Fatigue, sneezing, fever

MedDRA releases: 2024-11 · check-in free text available
2022-08-14
Report sent to call center — 3 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-08-15
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-04-11	Pfizer-BioNTech	No
2	2022-05-13	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-08-14	Unsuccessful

Free text

Release 12 — 3 months, dose 2, dependent

2022-08-14

Symptoms: Fatigue, sneezing, fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SD	Pyrexia	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release